CD8A and rheumatoid arthritis: We next compared the percentage of IFNγ-producing CD4+ and CD8+ effector T cells (CD4+IFN+ and CD8+IFN+) within PBMCs from both RA patients and Cs, activated with or without IL-6 (Figure 6).